• Home
  • Research
  • Research News
  • Comparison of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study

Comparison of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study

European Journal of Endocrinology, 07/08/2013


Bogazzi F et al. – The objective of the study was to compare the effect of different therapies for acromegaly on mortality. Therapies of acromegaly and comorbidities have lowered mortality to the level of the general population; SSA alone or following pituitary adenomectomy was comparable to curative neurosurgery on survival in non–diabetic patients; on the contrary, SSA as primary therapy, may be less effective than adenomectomy in reducing mortality in diabetic patients.

Print

Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now